Skip to content

Clinical trials

Phase 1/2 Major Depressive Disorder trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Phase: Phase 1/2 Country / region: United States Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20041
20052
20061
20071
20091
20101
20112
20122
20151
20161
20185
20201
20212
20221
20231
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Not yet recruiting3
Recruiting2
Terminated2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Laureate Institute for Brain Research, Inc.2
Mclean Hospital2
New York State Psychiatric Institute2
University of Cincinnati2
University of Texas Southwestern Medical Center2
Alkermes, Inc.1
BioLite, Inc.1
Bristol-Myers Squibb1
Cybin IRL Limited1
Dart NeuroScience, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder30
Dysthymic Disorder3
Mood Disorders3
Alcoholism2
Anxiety Disorders2
Bipolar Disorder2
Stress Disorders, Post-Traumatic2
Adjustment Disorders1
Generalized Anxiety Disorder1
Panic Disorder1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.